Ajanta Pharma Board of Directors

Get the latest insights into the leadership at Ajanta Pharma. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Gaurang ShahSr. VP – Legal, Company Secretary & Compliance Officer
Mannalal B AgrawalChairman
Madhusudan B AgrawalVice Chairman
Yogesh M AgrawalManaging Director
Rajesh M AgrawalJoint Managing Director
David RasquinhaNon Executive Independent Director
Medha JoshiNon Executive Independent Director
Rajesh DalalNon Executive Independent Director
Simi ThaparNon Executive Independent Director

Ajanta Pharma Share price

AJANTPHARM

2822.7

18.50 (0.66%)
NSE
BSE
Last updated on 30 Apr, 2026 | 15:51 IST
Today's High

2843.80

Today's Low

2790.00

52 Week Low

2329.90

52 Week High

3228.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Ajanta Pharma FAQs

The board at Ajanta Pharma consists of experienced professionals, including Gaurang Shah, Mannalal B Agrawal, and others, overseeing the company’s strategic and corporate governance.

Directors at Ajanta Pharma are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Gaurang Shah is the current chairman at Ajanta Pharma.

Executive directors at Ajanta Pharma are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Ajanta Pharma adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Ajanta Pharma, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost